摘要:
Disclosed are compounds of Formula I, Formula II, and Formula III. Also disclosed are salts of the compounds, pharmaceutical composition comprising the compounds or salts, and methods for treating HCV infection by administration of the compounds or salts.
摘要:
Provided are certain chemical entities, pharmaceutical compositions, and methods of treatment of a member of the flaviviradae family of viruses such as hepacivirus (Hepatitis C or HCV).
摘要:
The present invention provides compounds having the formula: wherein R1, R2, X1, X2, L1, L2, Y and Z are as defined in classes and subclasses herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., Aurora), and thus are useful, for example, for the treatment of Aurora mediated diseases.
摘要:
Provided are certain chemical entities, pharmaceutical compositions, and methods of treatment of a member of the flaviviradae family of viruses such as hepacivirus (Hepatitis C or HCV).
摘要:
The present invention provides compounds having the formula: wherein R1, R2, X1, X2, L1, L2, Y and Z are as defined in classes and subclasess herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., Aurora), and thus are useful, for example, for the treatment of Aurora mediated diseases.
摘要翻译:本发明提供具有下式的化合物:其中R 1,R 2,X 1,X 2, L 1,L 2,Y和Z如本文中的类别和亚临界所定义,以及其在本文中通常和在本文中描述的药物组合物,该化合物可用作 蛋白激酶抑制剂(例如Aurora),因此可用于治疗Aurora介导的疾病。
摘要:
Various technologies related to an enterprise computing platform are presented. A new level of software development can be achieved by avoiding the coding process. An enterprise computing platform having a variety of frameworks can be configured to operate in a variety of business domains. Features such as parallel computing, distributed computing, logical documents, document transformation, space visualization, data security, and others can be accomplished via configuration rather than coding. Considerable efficiency improvements in the software development process can be realized.
摘要:
Provided are certain chemical entities, pharmaceutical compositions, and methods of treatment of a member of the flaviviradae family of viruses such as hepacivirus (Hepatitis C or HCV).
摘要:
Provided are compounds of Formula (I) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the Flaviviridae family of viruses such as hepatitis C virus (HCV).
摘要:
A glycopolymer composition is provided comprising glycopolymer molecules having a polymer backbone; a first pendent unit comprising a linking group connected to said polymer backbone and a saccharide moiety connected to said linking group, optionally a second pendent unit; a phenyl ring at a first end of the polymer backbone; and a cyanoxyl group at the second end of the polymer backbone, useful as intermediates for making bioactive glycopolymers which bind to bioactive molecules, viruses, cells and substrates for protein separation, cell culture, ad drug delivery systems, as well as in targeting for treatment of wound healing and other pathological conditions.
摘要:
Various technologies related to an enterprise computing platform are presented. Documents in a framework can be edited via logical views as described. An enterprise computing platform having a variety of frameworks can be configured to operate in a variety of business domains. Features such as parallel computing, distributed computing, logical documents, document transformation, space visualization, data security, and others can be accomplished via configuration rather than coding.